Clinical Trial Update: First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery Lesions [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the first-in-human experience with a Biotronik drug-eluting stent in de novo coronary artery lesions, spanning Phase 1 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biotronik Drug-Eluting Stent

Snippet

Sponsor: Biotronik AG | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED